Stem Cells III Flashcards

1
Q

MAPK signaling is mediated by which protein?

A

Erk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the role of MAPK signaling?

A

Predisposes mouse ESCs to differentiation commitment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When can ESCs be established without LIF and serum?

A

When Erk is suppressed by a combination of Erk inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MAPK signaling is stimulated by which growth factor?

A

FGF4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

LIF and BMP4 (enable/counteract) the action of MAPK signaling that induces differentiation commitment

A

Counteract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the intrinsic factors that regulate ESC self-renewal?

A

Oct4, Nanog, Sox2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Oct4-negative embryos differentiate to what in vitro?

A

Trophectoderm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Oct4 (downregulation/upregulation) is the trigger for the formation of the primitive endoderm

A

Upregulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nanog over-expression leads to the formation of what cells?

A

LIF independent ESCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nanog KO leads to the formation of what type of cells?

A

Primitive endoderm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Altering the gene dosage of which intrinsic factors modifies the pluripotent phenotype of ESCs?

A

Oct4 and Nanog

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some active genes regulated by Oct4, Nanog and Sox2?

A

FGF2, STAT3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some silent genes regulated by Oct4, Nanog and Sox2?

A

HOXB1, PAX6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some pros of ESC application in the clinical setting?

A

Indefinite source of tissue engineering, any cell type can be produced, genetic manipulation, tissue regeneration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the cons of using ESCs in the clinical setting?

A

Tumorigenicity, low efficiency of differentiated target cells, immunocompatibility, ethics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the biological significance of animal cloning?

A

Differentiated cells retain a complete set of genetic information
Oocyte cytoplasm can reprogram somatic nuclei

17
Q

What experiment was done to see if ESCs can be generated from committed or terminally differentiated cells?

A

24 different genes selected from genes expressed in both oocytes and ESCs
Those genes were introduced into fibroblasts
One or combination of genes omitted to see what happens

18
Q

What was the results of omitting gene 7?

A

Production of ESCs

19
Q

Match the role of the Yamanaka factors to Oct4 and Sox2, c-Myc or KIf4
a. Serves as a co-factor for Oct4 and Sox2 and inhibits cell death
b. Restore and maintain pluripotency
c. Disrupts chromatin and allow Oct4 and Sox2 access to the genome

A

a. KIf4
b. Oct4 and Sox2
c. c-Myc

20
Q

How are ESCs and iPSCs similar?

A

Long term self-renewal activity

21
Q

Pluripotent fibroblasts contribute to the __________ of a developing fetus

A

Tissues

22
Q

Why are ESCs and iPSCs not identical?

A

No live birth of chimeric offspring, global gene expression and DNA methylation patterns

23
Q

Oct4, Nanog and Sox2 (negatively/positively) control the expression of each other

A

Positively

24
Q

What is the consequence of the forced activation of the network using Oct4, Sox2, c-Myc and KIf4?

A

Reprogramming of somatic cells to iSCs

25
Q

How are Yamanaka factors turned off and on?

A

Tetracyclin

26
Q

Why don’t the transgenes need to be integrated into the host cell genome?

A

The exogenous Yamanaka factors need to be expressed for a short period of time

27
Q

How are Yamanaka factors transferred?

A

Small molecules, adenoviruses, modified proteins